153 related articles for article (PubMed ID: 2167709)
21. Experimental infection of rhesus monkeys with SIV isolated from African green monkeys.
Herchenröder O; Stahl-Hennig C; Lüke W; Schneider J; Schulze G; Hartmann H; Schmidt H; Tenner-Racz K; Racz P; Hayami M
Intervirology; 1989; 30 Suppl 1():66-72. PubMed ID: 2540114
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV.
Marthas ML; Miller CJ; Sutjipto S; Higgins J; Torten J; Lohman BL; Unger RE; Ramos RA; Kiyono H; McGhee JR
J Med Primatol; 1992; 21(2-3):99-107. PubMed ID: 1433273
[TBL] [Abstract][Full Text] [Related]
23. Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challenge.
Osterhaus A; de Vries P; Morein B; Akerblom L; Heeney J
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1507-10. PubMed ID: 1466991
[TBL] [Abstract][Full Text] [Related]
24. Comparative approach to retroviral vaccines.
Burny A
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):389-92. PubMed ID: 8882316
[No Abstract] [Full Text] [Related]
25. Strategies for developing vaccines against acquired immunodeficiency syndrome.
Zhou EM; Kennedy RC
Biochim Biophys Acta; 1989 Dec; 989(3):301-13. PubMed ID: 2695171
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of protective efficacy of recombinant subunit vaccines against simian immunodeficiency virus infection of macaques.
Hu SL; Abrams K; Misher L; Stallard V; Moran P; Zarling JM; Langlois AJ; Kuller L; Morton WR; Benveniste RE
J Med Primatol; 1992; 21(2-3):119-25. PubMed ID: 1433262
[TBL] [Abstract][Full Text] [Related]
27. Characterization of group specific antibodies in primates: studies with SIV envelope in macaques.
Haigwood NL; Misher L; Chin SM; Blair M; Planelles V; Scandella CJ; Steimer KS; Gardner MB; Yilma T; Hirsch VM
J Med Primatol; 1992; 21(2-3):82-90. PubMed ID: 1433271
[TBL] [Abstract][Full Text] [Related]
28. Lymphoproliferative responses in macaques immunized with inactivated SIV vaccine.
Teng XC; Ashworth LA; Sharpe SA; Dennis MJ; Cranage MP
AIDS Res Hum Retroviruses; 1993 Aug; 9(8):799-801. PubMed ID: 8217348
[No Abstract] [Full Text] [Related]
29. Vaccination of pregnant cynomolgus monkeys with whole formalin-inactivated SIVmac251.
Titti F; Borsetti A; Geraci A; Sernicola L; Giuseppini L; Turillazzi GP; Pace M; Baroncelli S; Amadori A; Giovannetti A
J Med Primatol; 1992; 21(2-3):91-8. PubMed ID: 1433272
[TBL] [Abstract][Full Text] [Related]
30. Prevention of HIV-2 and SIVSM infection in cynomolgus monkeys by active or passive immunization.
Biberfield G; Putkonen P; Thorstensson R; Norrby E
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1511-3. PubMed ID: 1466992
[TBL] [Abstract][Full Text] [Related]
31. A formalin inactivated whole SIVmac vaccine in Ribi adjuvant protects against homologous and heterologous SIV challenge.
Putkonen P; Thorstensson R; Cranage M; Nilsson C; Ghavamzadeh L; Albert J; Greenaway P; Biberfeld G
J Med Primatol; 1992; 21(2-3):108-12. PubMed ID: 1433260
[TBL] [Abstract][Full Text] [Related]
32. Virus-specific helper T cell response of macaques immunized with inactivated whole SIV is not correlated with reactivity against cellular components of vaccine preparation.
Dittmer U; Lüke W; Stahl-Hennig C; Hunsmann G; Voss G
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):329-30. PubMed ID: 8068411
[No Abstract] [Full Text] [Related]
33. SIV vaccine protection of rhesus monkeys.
Gardner MB; Carlson JR; Jennings M; Rosenthal A; Langlois A; Haynes B; Bolognesi D; Palker TJ
Biotechnol Ther; 1991; 2(1-2):9-19. PubMed ID: 1845125
[TBL] [Abstract][Full Text] [Related]
34. Complement-mediated, infection-enhancing antibodies in plasma from vaccinated macaques before and after inoculation with live simian immunodeficiency virus.
Montefiori DC; Murphey-Corb M; Desrosiers RC; Daniel MD
J Virol; 1990 Oct; 64(10):5223-5. PubMed ID: 2168999
[TBL] [Abstract][Full Text] [Related]
35. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus.
Kestler H; Kodama T; Ringler D; Marthas M; Pedersen N; Lackner A; Regier D; Sehgal P; Daniel M; King N
Science; 1990 Jun; 248(4959):1109-12. PubMed ID: 2160735
[TBL] [Abstract][Full Text] [Related]
36. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
[TBL] [Abstract][Full Text] [Related]
37. Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus.
Spear GT; Takefman DM; Sullivan BL; Landay AL; Jennings MB; Carlson JR
Virology; 1993 Aug; 195(2):475-80. PubMed ID: 8337824
[TBL] [Abstract][Full Text] [Related]
38. Nonhuman primates and the acquired immunodeficiency syndrome: a union of necessity.
Fultz PN
J Med Primatol; 1989; 18(2):73-83. PubMed ID: 2541246
[TBL] [Abstract][Full Text] [Related]
39. Transmission of the simian immunodeficiency virus SIVmne in macaques and baboons.
Morton WR; Kuller L; Benveniste RE; Clark EA; Tsai CC; Gale MJ; Thouless ME; Overbaugh J; Katze MG
J Med Primatol; 1989; 18(3-4):237-45. PubMed ID: 2547959
[TBL] [Abstract][Full Text] [Related]
40. Immunization of rhesus monkeys with high- and low-dose Tween-ether-disrupted SIVMAC.
Voss G; Stahl-Hennig C; Petry H; Coulibaly C; Nick S; Fuchs D; Wachter H; Lüke W; Hunsmann G
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1397-400. PubMed ID: 1466966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
